|
 |
Beauty > In Vitro
/In_vitro_fertilisation.gif)
The following information is about In Vitro.
In Vitro Defined
From the Latin meaning in the living body. In vitro tests do not involve the use of living vertebrate animals. Note: In vivo studies are conducted using animals.
This definition is in context to Beauty. See more contextual defintions for In Vitro.
What Is Garlic Used for Today?
Published September 6, 2008, 10:25 pm, ThirdAge
Garlic is widely used as an all-around treatment for preventing or slowing the progression of atherosclerosis (the cause of most heart attacks and strokes).
JCI online early table of contents: Sept. 5, 2008
Published September 5, 2008, 2:15 pm, EurekAlert!
( Journal of Clinical Investigation ) This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, September 5, 2008, in the JCI: "How STDs increase the risk of becoming infected with HIV"; "HIV-stimulated immune cells generate cells with immunosuppressive properties"; "How immune cells help tumors grow blood vessels"; "Type 2 ...
Merck Serono And ZymoGenetics Restructure Partnership
Published September 5, 2008, 5:24 am, PharmaceuticalOnline
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and ZymoGenetics, Inc. , Seattle, United States, recently announced a restructuring of their partnership.
Antioxidants - friend or foe?
Published September 4, 2008, 1:37 am, uniprotokolle
Particularly in the field of advertising and in popular scientific journals, antioxidants such as ß-carotene (from carrots) or lycopenes (from tomatoes) and the vitamins C and E are one-sidedly portrayed as substances capable of offering protection against cancer or ageing because they diminish or prevent the effects of free radicals.
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Published September 3, 2008, 9:24 am, Centre Daily Times
ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The application, submitted on August 29, 2008, was prepared in conjunction ...
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance
NEW YORK----ImClone Systems Incorporated today announced that it has submitted an application to the U.S. Food and Drug Administration to broaden the use of ERBITUX® to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck .
ZymoGenetics and Merck Serono Restructure Partnership
Published September 3, 2008, 6:15 am, Centre Daily Times
ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license. By making this election, ZymoGenetics will no longer be responsible for funding development costs, and ...
ZymoGenetics and Merck Serono Restructure Partnership
Published September 3, 2008, 3:00 am, Business Wire via Yahoo! Finance
SEATTLE----ZymoGenetics, Inc. today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license.
Merck Serono and ZymoGenetics Restructure Partnership
Published September 3, 2008, 3:00 am, PR Newswire via Yahoo! Finance
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and ZymoGenetics, Inc. , Seattle, United States, today announced a restructuring of their partnership.
MOR103 Anti-GM-CSF Antibody Shows Subpicomolar Affinity For Its Target Molecule
Published September 2, 2008, 8:08 am, Medical News Today
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
Are you looking for additional Beauty > In Vitro news? Try our new "In Vitro News Focus" area.
Off-site In Vitro Links, User Submitted
The following links have been collected through user bookmark submission in the In Vitro category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Wed Aug 6
Mon Aug 4
Tue Jul 29
Sun Jul 20
Sat Jul 5
Fri Jul 4
Tue May 27
Mon Apr 28
Sun Apr 27
Fri Apr 25
- Aitai-2: Great song
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > In Vitro. If you would like to find related tags we recommend Tag Patterns > In Vitro
Off-site In Vitro Research Links
If you still need additional information on In Vitro then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Beauty Topics
Everything you need to know about Beauty
Beauty
If you know the Beauty Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Beauty.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.